The patient¿s attorney alleged a deficiency against the device.Additional information has been requested, but not yet received.Product was used for therapeutic treatment.Per additional information received on february 14, 2019, the patient has experienced recurrent mechanical dysfunction of the genitourinary device, scar tissue, recurrent granulation tissue, recurrent vaginal polyps, slowing of the urinary stream, urinary urgency, polypoid reactive granulation tissue, vaginal foreign body, and granuloma.She has required multiple non-surgical interventions as well as multiple surgical interventions.Per additional information received on 11oct2021, the patient has experienced recurrent vaginal polyps, vaginal growth, urinary urgency, vaginal atrophy, urge incontinence, burning sensation while urination, urinary leakage, pain while walking, vaginal bleeding, mixed incontinence, vaginal discharge, recurrent stress urinary incontinence, vaginal spotting, recurrence of vaginal granulation tissue, discomfort in the vaginal area, pelvic pain, overactive bladder syndrome, nocturia, vaginal foreign body and granuloma, dyspareunia, pain during sexual intercourse, hernia, recurrent vaginal pain, urethral hypermobility and required additional surgical and non-surgical interventions.
|